136 related articles for article (PubMed ID: 37166928)
1. Intrathymic AAV gene delivery.
Li W
Blood; 2023 May; 141(19):2286-2288. PubMed ID: 37166928
[No Abstract] [Full Text] [Related]
2. Intrathymic adeno-associated virus gene transfer rapidly restores thymic function and long-term persistence of gene-corrected T cells.
Pouzolles M; Machado A; Guilbaud M; Irla M; Gailhac S; Barennes P; Cesana D; Calabria A; Benedicenti F; Sergé A; Raman I; Li QZ; Montini E; Klatzmann D; Adjali O; Taylor N; Zimmermann VS
J Allergy Clin Immunol; 2020 Feb; 145(2):679-697.e5. PubMed ID: 31513879
[TBL] [Abstract][Full Text] [Related]
3. Intrathymic AAV delivery results in therapeutic site-specific integration at TCR loci in mice.
Calabria A; Cipriani C; Spinozzi G; Rudilosso L; Esposito S; Benedicenti F; Albertini A; Pouzolles M; Luoni M; Giannelli S; Broccoli V; Guilbaud M; Adjali O; Taylor N; Zimmermann VS; Montini E; Cesana D
Blood; 2023 May; 141(19):2316-2329. PubMed ID: 36790505
[TBL] [Abstract][Full Text] [Related]
4. Induction of immune tolerance to a therapeutic protein by intrathymic gene delivery.
Chu Q; Moreland RJ; Gao L; Taylor KM; Meyers E; Cheng SH; Scheule RK
Mol Ther; 2010 Dec; 18(12):2146-54. PubMed ID: 20664526
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated virus vector as a platform for gene therapy delivery.
Wang D; Tai PWL; Gao G
Nat Rev Drug Discov; 2019 May; 18(5):358-378. PubMed ID: 30710128
[TBL] [Abstract][Full Text] [Related]
6. More expansive gene transfer to the rat CNS: AAV PHP.EB vector dose-response and comparison to AAV PHP.B.
Dayton RD; Grames MS; Klein RL
Gene Ther; 2018 Aug; 25(5):392-400. PubMed ID: 30013186
[TBL] [Abstract][Full Text] [Related]
7. Comparison of lentiviral and sleeping beauty mediated αβ T cell receptor gene transfer.
Field AC; Vink C; Gabriel R; Al-Subki R; Schmidt M; Goulden N; Stauss H; Thrasher A; Morris E; Qasim W
PLoS One; 2013; 8(6):e68201. PubMed ID: 23840834
[TBL] [Abstract][Full Text] [Related]
8. AAV-ie enables safe and efficient gene transfer to inner ear cells.
Tan F; Chu C; Qi J; Li W; You D; Li K; Chen X; Zhao W; Cheng C; Liu X; Qiao Y; Su B; He S; Zhong C; Li H; Chai R; Zhong G
Nat Commun; 2019 Aug; 10(1):3733. PubMed ID: 31427575
[TBL] [Abstract][Full Text] [Related]
9. Toward gene therapy for human CD3 deficiencies.
Pacheco-Castro A; Martín-Fernández JM; Millán R; Sanal O; Allende L; Regueiro JR
Hum Gene Ther; 2003 Nov; 14(17):1653-61. PubMed ID: 14633407
[TBL] [Abstract][Full Text] [Related]
10. Dual AAV Vectors for Stargardt Disease.
Trapani I
Methods Mol Biol; 2018; 1715():153-175. PubMed ID: 29188512
[TBL] [Abstract][Full Text] [Related]
11. Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo.
Qing K; Li W; Zhong L; Tan M; Hansen J; Weigel-Kelley KA; Chen L; Yoder MC; Srivastava A
J Virol; 2003 Feb; 77(4):2741-6. PubMed ID: 12552015
[TBL] [Abstract][Full Text] [Related]
12. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
Schön C; Biel M; Michalakis S
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
[TBL] [Abstract][Full Text] [Related]
13. Microvesicle-associated AAV vector as a novel gene delivery system.
Maguire CA; Balaj L; Sivaraman S; Crommentuijn MH; Ericsson M; Mincheva-Nilsson L; Baranov V; Gianni D; Tannous BA; Sena-Esteves M; Breakefield XO; Skog J
Mol Ther; 2012 May; 20(5):960-71. PubMed ID: 22314290
[TBL] [Abstract][Full Text] [Related]
14. Gene delivery to the eye using adeno-associated viral vectors.
Martin KR; Klein RL; Quigley HA
Methods; 2002 Oct; 28(2):267-75. PubMed ID: 12413426
[TBL] [Abstract][Full Text] [Related]
15. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
16. Adeno Associated Virus (AAV) as a Tool for Clinical and Experimental Delivery of Target Genes into the Mammalian Retina.
Hori T; Fukutome M; Koike C
Biol Pharm Bull; 2019; 42(3):343-347. PubMed ID: 30828065
[TBL] [Abstract][Full Text] [Related]
17. Pseudotyped AAV vectors for constitutive and regulated gene expression in the eye.
Auricchio A
Vision Res; 2003 Apr; 43(8):913-8. PubMed ID: 12668060
[TBL] [Abstract][Full Text] [Related]
18. One episode of low intensity aerobic exercise prior to systemic AAV9 administration augments transgene delivery to the heart and skeletal muscle.
Pacak CA; Suzuki-Hatano S; Khadir F; Daugherty AL; Sriramvenugopal M; Gosiker BJ; Kang PB; Cade WT
J Transl Med; 2023 Oct; 21(1):748. PubMed ID: 37875924
[TBL] [Abstract][Full Text] [Related]
19. Versatility of AAV vectors for retinal gene transfer.
Surace EM; Auricchio A
Vision Res; 2008 Feb; 48(3):353-9. PubMed ID: 17923143
[TBL] [Abstract][Full Text] [Related]
20. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein.
Kessler PD; Podsakoff GM; Chen X; McQuiston SA; Colosi PC; Matelis LA; Kurtzman GJ; Byrne BJ
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14082-7. PubMed ID: 8943064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
